This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
A promising Biotech unicorn headquartered in a Tier-1 city in China. Dedicated to developing groundbreaking first-in-class innovative drugs, the company has successfully advanced its core assets into Phase II clinical trials with solid data readouts and strong financial backing. Led by a visionary founder and a scientific committee of industry veterans. You will be joining a highly dynamic and ambitious executive board, reporting directly to the CEO, and acting as the primary bridge between the company's scientific innovations and the global capital markets.
Job Responsibility:
Spearhead the company's upcoming HKEX Chapter 18A IPO process, leading the coordination with global sponsors, legal counsels, and auditors
Formulate and execute comprehensive capital market strategies, actively pitch to top-tier institutional investors, and secure future financings
Oversee group-level financial planning, build complex valuation models, and provide critical financial leadership for cross-border Business Development (License-in/out) and M&A activities
Requirements:
Proven experience in successfully executing HKEX 18A IPOs, either as an in-house Biotech CFO or as a senior investment banker (VP/ED/MD level) from top-tier global or domestic securities firms
Exceptional financial modeling and valuation capabilities, with a deep understanding of biotech pipelines, clinical data, and BD transaction structuring
Outstanding communication and presentation skills in both English and Mandarin, with established relationships with healthcare-focused long-only funds and institutional investors